Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential


Glaxosmithkline Regulatory News (GSK)



Regulatory News for Glaxosmithkline (GSK)


Share Price: 1,595.40Bid: 1,595.20Ask: 1,595.40Change: 0.20 (+0.01%)Riser - Glaxosmithkline
Spread: 0.20Spread as %: 0.01%Open: 1,607.40High: 1,608.00Low: 1,587.20Yesterday’s Close: 1,595.20





DateSourceHeadlineCategory
12-Jun-19 17:10RNSDirector/PDMR ShareholdingDirectors' Dealings
07-Jun-19 07:00RNSFDA approval for Nucala self-administrationCompany Announcement - General
04-Jun-19 08:00RNSCHMP positive on GSK's Nucala self-administrationCompany Announcement - General
03-Jun-19 14:31RNSTotal Voting RightsHolding(s) in Company
24-May-19 10:54RNSDirector/PDMR ShareholdingDirectors' Dealings
20-May-19 13:44RNSDirector/PDMR ShareholdingDirectors' Dealings
13-May-19 17:44RNSBlock listing Interim ReviewCompany Announcement - General
13-May-19 16:19RNSDirector/PDMR ShareholdingDirectors' Dealings
08-May-19 18:23RNSResult of AGM & GMResults and Trading Reports
02-May-19 17:07RNSTrelegy Ellipta asthma study met primary endpointCompany Announcement - General
01-May-19 15:11RNSDirector/PDMR ShareholdingDirectors' Dealings
01-May-19 14:32RNSTotal Voting RightsHolding(s) in Company
01-May-19 12:00RNS1st Quarter ResultsResults and Trading Reports
29-Apr-19 12:00RNSViiV submits NDA for HIV monthly 2 drug injectableCompany Announcement - General
26-Apr-19 16:16RNSViiV receives CHMP Positive Opinion for DovatoCompany Announcement - General
16-Apr-19 17:36RNSDirector/PDMR ShareholdingDirectors' Dealings
16-Apr-19 17:35RNSDirector/PDMR ShareholdingDirectors' Dealings
16-Apr-19 17:23RNSDirector/PDMR ShareholdingDirectors' Dealings
16-Apr-19 17:14RNSDirector/PDMR ShareholdingDirectors' Dealings
15-Apr-19 14:45RNSDirector/PDMR ShareholdingDirectors' Dealings
12-Apr-19 16:47RNSDirector/PDMR ShareholdingDirectors' Dealings
12-Apr-19 16:33RNSDirector/PDMR ShareholdingDirectors' Dealings
11-Apr-19 17:01RNSDirector/PDMR ShareholdingDirectors' Dealings
09-Apr-19 07:00RNSFDA approves ViiV's two-drug HIV regimen, DovatoCompany Announcement - General
02-Apr-19 13:00RNSPublication of AGM and GM Shareholder DocumentsCompany Announcement - General
01-Apr-19 16:36RNSTotal Voting RightsHolding(s) in Company
28-Mar-19 16:15RNSGSK reporting changes - product sales and IFRS 16Company Announcement - General
21-Mar-19 16:00RNSGSK announces further positive data from DREAMM-1Company Announcement - General
19-Mar-19 17:45RNSData from GARNET study evaluating dostarlimabCompany Announcement - General
18-Mar-19 07:00RNSGSK Annual Report 2018 on Form 20-FCompany Announcement - General


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.